Get the Stockscreener App
3.42
2.29%
-0.08
After Hours:
3.50
0.08
+2.34%
Nuwellis Inc stock is traded at $3.42, with a volume of 42,516.
It is down -2.29% in the last 24 hours and down -18.18% over the past month.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
See More
Previous Close:
$3.50
Open:
$3.5
24h Volume:
42,516
Relative Volume:
0.05
Market Cap:
$3.09M
Revenue:
$8.97M
Net Income/Loss:
$-15.21M
P/E Ratio:
-0.0294
EPS:
-116.51
Net Cash Flow:
$-10.84M
1W Performance:
-3.12%
1M Performance:
-18.18%
6M Performance:
+267.02%
1Y Performance:
+105.41%
1-Day Range:
$3.34
$3.50
1-Week Range:
$3.34
$3.92
52-Week Range:
$0.19
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
Name
Nuwellis Inc
Sector
Industry
Phone
952-345-4200
Address
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
3.42 | 3.16M | 8.97M | -15.21M | -10.84M | -116.51 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | ROTH MKM | Buy |
Nuwellis Inc Stock (NUWE) Latest News
Combining machine learning predictions for Nuwellis Inc.July 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com
Should you wait for a breakout in Nuwellis Inc.M&A Rumor & AI Driven Price Forecasts - newser.com
Real time social sentiment graph for Nuwellis Inc.Gap Up & Free Expert Approved Momentum Trade Ideas - newser.com
Momentum divergence signals in Nuwellis Inc. chartJuly 2025 Pullbacks & High Conviction Buy Zone Alerts - newser.com
Is Nuwellis Inc. reversing from oversold territoryDollar Strength & High Yield Equity Trading Tips - newser.com
Key resistance and support levels for Nuwellis Inc.Short Setup & Weekly Market Pulse Updates - newser.com
Will Nuwellis Inc. stock go up soonWeekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Why Nuwellis Inc. is moving todayWeekly Trade Report & High Yield Equity Trading Tips - newser.com
Nuwellis Appoints John L. Erb as Interim CFO - TipRanks
NuwellisRobert B. Scott resigns as CFO of Nuwellis - MarketScreener
Nuwellis Receives NIH Grant to Advance its Pediatric CRRT Platform - Medical Product Outsourcing
Nuwellis Inc Stock Analysis and ForecastInsider Trading Activity & Outperform the Market with Aggressive Picks - earlytimes.in
What drives Nuwellis Inc stock priceSector-Based Investing & Small Investment Trading Plans - earlytimes.in
Tools to assess Nuwellis Inc.’s risk profilePortfolio Value Report & Real-Time Market Trend Scan - newser.com
How interest rate cuts could boost Nuwellis Inc. stock2025 Growth vs Value & AI Enhanced Trading Signals - newser.com
Can technical indicators confirm Nuwellis Inc.’s reversalMarket Risk Summary & Growth Focused Investment Plans - newser.com
What momentum shifts mean for Nuwellis Inc.2025 Pullback Review & Verified Momentum Watchlists - newser.com
Using RSI to spot recovery in Nuwellis Inc.Trade Risk Report & Verified Technical Signals - newser.com
Nuwellis Announces ULTRA-Peds Registry Findings - TipRanks
Nuwellis announces findings from ULTRA-Peds registry on Aquadex System use - Investing.com
Nuwellis reports 92% survival rate in pediatric Aquadex therapy study - Investing.com
Nuwellis reports 92% survival rate in pediatric Aquadex therapy study By Investing.com - Investing.com Australia
Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex® - The Manila Times
Nuwellis, Inc. Announces Positive Findings from ULTRA-Peds Registry on Aquadex Therapy for Critically Ill Children - Quiver Quantitative
How moving averages guide Nuwellis Inc. tradingProfit Target & AI Based Trade Execution Alerts - newser.com
Is Nuwellis Inc. showing signs of accumulation2025 Price Action Summary & Smart Investment Allocation Tips - newser.com
Detecting support and resistance levels for Nuwellis Inc.Gap Down & Comprehensive Market Scan Reports - newser.com
Is Nuwellis Inc a good long term investmentMarket Capitalization Trends & Smart Beta Strategies That Actually Work - Early Times
Nuwellis, Inc. Stock Plummets to New 52-Week Low of $3.54 - Markets Mojo
Nuwellis introduces 24-hour circuit for Aquadex therapy in the U.S. - MSN
Nuwellis, Inc. Stock Plummets to New 52-Week Low of $3.65 - Markets Mojo
Earnings Report: Does Nuwellis Inc have pricing powerJuly 2025 Catalysts & Real-Time Buy Zone Alerts - خودرو بانک
Technical Analysis: What is the earnings history of Nuwellis IncWeekly Profit Recap & Target Return Focused Picks - خودرو بانک
Nuwellis Inc Stock (NUWE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):